Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Becker Muscular Dystrophy: early-phase trial registry

4 of 13 indexed Becker Muscular Dystrophy trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 4 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Becker Muscular Dystrophy: 13 US clinical trials tracked, 4 recruiting.

Becker Muscular Dystrophy is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Cedars-Sinai Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition becker-muscular-dystrophy

OPEN 4 | RECR 31% | LATE 1 | EARLY 5 | RANK #1315 | SPON 3

Nearest open-share peer: Acute Decompensated Heart Failure (31% recruiting · 13 trials)

ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Becker Muscular Dystroph (th…31%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Becker Muscular Dystrophy

Becker Muscular Dystrophy lists 4 open slots (31% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Becker Muscular Dystrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Becker Muscular Dystrophy is recruiting below its size-band peers.

    4 of 13 indexed trials (30.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Becker Muscular Dystrophy research.

    Cedars-Sinai Medical Center accounts for 3 of 13 trials (23.1%). 11 distinct sponsors appear on at least one study for this condition label.

  3. Typical Becker Muscular Dystrophy enrolment sits around 80 participants.

    Median target enrolment is 80 among the 13 trials that report a genuine target (sentinel values excluded). 7 of those (53.8%) plan for fewer than 100 participants.

  4. Becker Muscular Dystrophy splits between interventional and observational designs.

    6 interventional and 7 observational studies make up this index (46.2% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 13Phase 22Phase 41

Open and recent trials

13 total, page 1 of 1

RECRUITING 10,000 participants

The Duchenne Registry

The Duchenne Registry

NCT02069756

RECRUITING 5,000 participants

CureDuchenne Link®: A Resource for Research

CureDuchenne

NCT04972604

RECRUITING 550 participants

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

University of Florida

NCT01484678

RECRUITING 465 participants

Biomarker Development for Muscular Dystrophies

Massachusetts General Hospital

NCT05019625

ACTIVE NOT RECRUITING 250 participants

Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD

Nationwide Children's Hospital

NCT02972580

ACTIVE NOT RECRUITING Phase 2 244 participants

Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)

Edgewise Therapeutics

NCT05291091

ACTIVE NOT RECRUITING 80 participants

Defining Endpoints in Becker Muscular Dystrophy

Virginia Commonwealth University

NCT05257473

COMPLETED 60 participants

Evaluation of Limb-Girdle Muscular Dystrophy

Cooperative International Neuromuscular Research Group

NCT00893334

COMPLETED Phase 4 48 participants

Tadalafil in Becker Muscular Dystrophy

Cedars-Sinai Medical Center

NCT01070511

COMPLETED Phase 1 22 participants

Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy

Epirium Bio

NCT04386304

COMPLETED Phase 2 19 participants

Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy

Cedars-Sinai Medical Center

NCT02147639

COMPLETED Phase 1 11 participants

Sodium Nitrate to Improve Blood Flow

Cedars-Sinai Medical Center

NCT02847975

COMPLETED Phase 1 4 participants

Gentamicin Treatment of Muscular Dystrophy

National Institute of Neurological Disorders and Stroke (NINDS)

NCT00005574

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 2
Phase 4 1

Named interventions

Most-linked intervention names on Becker Muscular Dystrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
2 trials
Sodium nitrate Dietary supplement
1 trials
(+)-Epicatechin Drug
1 trials
Increased exercise intensity Procedure
1 trials
Sodium Nitrate - double dose Dietary supplement
1 trials
Sodium Nitrate Dietary supplement
1 trials
Sevasemten 12.5 mg Drug
1 trials
Sevasemten 5 mg Drug
1 trials

US sites by state

Facility locations filed on Becker Muscular Dystrophy trials. A trial with sites in several states counts in each.

California 7 trials
North Carolina 4 trials
Pennsylvania 3 trials
Ohio 3 trials
Missouri 3 trials
Maryland 3 trials
Kansas 3 trials
Iowa 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Becker Muscular Dystrophy page

13 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Becker Muscular Dystrophy condition card totals 13 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.